Complications co-morbidity, and blood glucose control in type 2 diabetes mellitus patients in Germany -: results from the CODE-2™ study

被引:76
作者
Liebl, A
Neiss, A
Spannheimer, A
Reitberger, U
Wieseler, B
Stammer, H
Goertz, A
机构
[1] Fachklin Bad Heilbrunn, Diabet Zentrum, D-83670 Bad Heilbrunn, Germany
[2] Tech Univ Munich, Inst Med Stat & Epidemiol, D-8000 Munich, Germany
[3] Kendle Int Inc, Munich, Germany
[4] GlaxoSmithKline GmbH & Co KG, Munich, Germany
关键词
diabetes mellitus; complications; blood glucose; prevalence; incidence;
D O I
10.1055/s-2002-19988
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In this study, prevalence and incidence of complications as well as co-morbidity in type 2 diabetes patients in Germany were evaluated as part of a cost-of-illness study (CODE-2(TM), Costs Of Diabetes in Europe - Type 2) In a pre-study, 197 general practitioners and diabetes specialists all over Germany provided data on the complication status of 2701 randomly selected patients with type 2 diabetes. The patients were grouped into five mutually exclusive strata. This pre-study was performed to generate a general overview on complication status to select proper patients for the main study. The main study was performed on stratified samples derived from the pre-study. Irrespective of the real prevalence of the five strata, an equal number of 160 were randomly selected from each stratum. Thus, rare complications were also covered in the study. Data from 809 patients were collected retrospectively on the basis of medical files during interviews with the physician. To achieve representative estimates of absolute prevalence and incidence of diabetes-related complications in Germany, results were weighted using frequencies of the strata.
引用
收藏
页码:10 / 16
页数:7
相关论文
共 24 条
[1]   The progressive cost of complications in type 2 diabetes mellitus [J].
Brown, JB ;
Pedula, KL ;
Bakst, AW .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (16) :1873-1880
[2]   Low prevalence of long-term complications in non-insulin-dependent diabetes mellitus in France: A multicenter study [J].
Delcourt, C ;
Vauzelle-Kervroedan, F ;
Cathelineau, G ;
Papoz, L .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 1998, 12 (02) :88-95
[3]  
*FED STAT OFF, 1998, HLTH REP GERM, P237
[4]  
FREI U, 2000, NIERENERSATZTHERAPIE
[5]  
GLOESER S, 1996, DTSCH ARZTEBLATT, V8, pA438
[6]  
HASCHE H, 1997, DTSCH ARZTEBLATT, V94, P2429
[7]  
HASCHE U, 1997, FORTSCHR MED, V115, P43
[8]  
Janka H., 1996, DIABETOLOGIE INFORMA, V4, P243
[9]  
JUNGHANEL J, 2000, EXPCLIN ENDOCRINO S1, V108, P163
[10]   THE COSTS OF DIABETES AND ITS COMPLICATIONS [J].
LEESE, B .
SOCIAL SCIENCE & MEDICINE, 1992, 35 (10) :1303-1310